Growth hormone directly favors hepatic ketogenesis in persons with prediabetes or type 2 diabetes mellitus treated with empagliflozin-Reference-Cited by-同舟云学术

Growth hormone directly favors hepatic ketogenesis in persons with prediabetes or type 2 diabetes mellitus treated with empagliflozin

Published:2021-04-19 Issue:2 Volume:73 Page:325-330
ISSN:1355-008X
Container-title:Endocrine
language:en
Short-container-title:Endocrine

Author:

da Rocha Aline Franco,Pereira Junior Paulo Sergio,Calefi Gabriela Simonetti,Marquezine Guilherme Figueiredo,Morimoto Helena Kaminami,Mazzuco Tania Longo,de Faria Eliana Cotta,Urbano Mariana Ragassi,Carrilho Alexandre Jose Faria^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Link

https://link.springer.com/content/pdf/10.1007/s12020-021-02730-0.pdf

Reference17 articles.

1. T. Heise, E. Seewaldt-Becker, S. Macha, S. Hantel, S. Pinnetti, L. Seman et al. Safety, tolerability, pharmacokinetics and pharmacodynamics following 4 weeks’ treatment with empagliflozin once daily in patients with type 2 diabetes. Diabetes Obes. Metab. 15, 613–21 (2013). https://doi.org/10.1111/dom.12073

2. C. Bonner, J. Kerr-Conte, V. Gmyr, G. Queniat, E. Moerman, J. Thévenet et al. Inhibition of the glucose transporter SGLT2 with dapagliflozin in pancreatic alpha cells triggers glucagon secretion. Nat. Med. 21, 512–7 (2015). https://doi.org/10.1038/nm.3828

3. H. Qiu, A. Novikov, V. Vallon, Ketosis and diabetic ketoacidosis in response to SGLT2 inhibitors: basic mechanisms and therapeutic perspectives. Diabetes Metab. Res. Rev. 33, 1–9 (2017). https://doi.org/10.1002/dmrr.2886

4. N. Moøller, J.O.L. Joørgensen, Effects of growth hormone on glucose, lipid, and protein metabolism in human subjects. Endocr. Rev. 30, 152–77 (2009). https://doi.org/10.1210/er.2008-0027

5. D. RABINOWITZ, K.L. ZIERLER, A metabolic regulating device based on the actions of human growth hormone and of insulin, singly and together, on the human forearm. Nature 199, 913–5 (1963). https://doi.org/10.1038/199913a0

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Diabetes mellitus in acromegaly: prevalence, pathophysiological particulars and treatment strategies;Almanac of Clinical Medicine;2023-12-09

2. How to position sodium-glucose co-transporter 2 inhibitors in the management of diabetes in acromegaly patients;Endocrine;2023-03-31

3. New insights into cellular links between sodium–glucose cotransporter‐2 inhibitors and ketogenesis;Journal of Cellular Biochemistry;2022-09-25

4. Mini Review: Effect of GLP-1 Receptor Agonists and SGLT-2 Inhibitors on the Growth Hormone/IGF Axis;Frontiers in Endocrinology;2022-02-21

5. Towards Understanding the Direct and Indirect Actions of Growth Hormone in Controlling Hepatocyte Carbohydrate and Lipid Metabolism;Cells;2021-09-24